摘要
背景:生物活性植物次生代谢产物具有复杂的化学结构,对每个植物种属都有特异性,并在微小数量内积累.。不断增长的市场需求,许多植物在它们的自然栖息地被过度采集作为药用植物,在这个过程中,产生了很多濒危物种。 目的:当今社会的挑战是开发出可持续生产的植物化学物质,在自然资源中。癌症是一个主要的健康问题,造成全球每年约820万人死亡。因此我们重点从植物及生物技术生产中筛查癌症治疗药物。 方法和结果:广泛的文献回顾表明,尽管广泛的植物化学物质受抗增殖活性的影响,只有少数的植物药物列入体内(ATC)作为抗肿瘤药物的分类中。这些措施包括长春花生物碱及其衍生物(l01ca),鬼臼毒素衍生物(l01cb),紫杉醇及其衍生物(l01cd),以及喜树碱衍生物(l01xx)。这些化合物都有一个复杂的化学结构,自然界分布稀少,附加值高.。在描述这些抗癌化合物的化学结构、自然资源和生物活动时,重点研究植物细胞工厂在生物技术生产的现状。 结论:深入研究目标植物代谢及其调节以增加植物细胞工厂的生物技术生产并最终实现这些生物可持续过程在工业水平的合成需要。
关键词: 喜树碱衍生物,植物抗癌化合物,植物细胞培养,紫杉烷类,鬼臼毒素衍生物,长春花生物碱。
Current Medicinal Chemistry
Title:Plant Anti-cancer Agents and their Biotechnological Production in Plant Cell Biofactories
Volume: 23 Issue: 39
Author(s): Liliana Lalaleo, Abbas Khojasteh, Mohammad Fattahi, Mercedes Bonfill, Rosa M. Cusido, Javier Palazon
Affiliation:
关键词: 喜树碱衍生物,植物抗癌化合物,植物细胞培养,紫杉烷类,鬼臼毒素衍生物,长春花生物碱。
摘要: Background: Bioactive plant secondary metabolites have complex chemical structures, which are specific to each plant species/family, and accumulate in tiny amounts. The growing market demand for many phytochemicals can lead to the over-harvesting of medicinal plants in their natural habitat, endangering species in the process.
Objective: An ongoing challenge for our society is therefore to develop a bio-sustainable production of phytochemicals, among other natural resources. Cancer is currently a major health problem, responsible for approximately 8.2 million deaths per year worldwide. We therefore focused this review on cancer therapeutic agents from plants and their biotechnological production.
Method and Results: An extensive review of the literature shows that although a wide range of phytochemicals have demonstrated anti-proliferative activity in vitro, only a few examples of plant-based drugs are included in the Anatomical Therapeutic Chemical (ATC) classification as antineoplastic agents. These include vinca alkaloids and their derivatives (L01CA), podophyllotoxin derivatives (L01CB), and paclitaxel and its derivatives (L01CD), as well as camptothecin derivatives (L01XX). These compounds all have in common a complex chemical structure, a scarce distribution in nature, and a high added value. After describing the chemical structures, natural sources and biological activities of these anticancer compounds, we focus on the state of the art in their biotechnological production in plant cell biofactories.
Conclusion: More in-depth studies are required on the biosynthesis of target plant metabolites and its regulation in order to increase their biotechnological production in plant cell factories and ultimately implement these biosustainable processes at an industrial level.
Export Options
About this article
Cite this article as:
Liliana Lalaleo, Abbas Khojasteh, Mohammad Fattahi, Mercedes Bonfill, Rosa M. Cusido, Javier Palazon , Plant Anti-cancer Agents and their Biotechnological Production in Plant Cell Biofactories, Current Medicinal Chemistry 2016; 23 (39) . https://dx.doi.org/10.2174/0929867323666161024145715
DOI https://dx.doi.org/10.2174/0929867323666161024145715 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements